Japan
Japan Cosmetic Compliance & PMD Act Regulatory Support
Japan operates one of Asia’s most structured and enforcement-led cosmetic regulatory systems under the Pharmaceutical and Medical Device Act (PMD Act). Cosmetic and quasi-drug products must meet strict ingredient, safety, labelling, and classification requirements, with local market accountability mandatory for imported goods.
Whether you are launching cosmetics in Japan for the first time or expanding an existing Asia-Pacific portfolio, gcrs group supports brands at every stage of Japanese compliance—ensuring products are correctly classified, safely substantiated, and legally placed on the market.
Japan Cosmetic Compliance & Market Accountability
Cosmetic compliance in Japan is a pre-market, classification-driven system. Products must be correctly classified as cosmetics or quasi-drugs before entry, with regulatory obligations varying significantly between categories.
Legal responsibility sits with the local Marketing Authorisation Holder (MAH) or appointed Japanese entity placing products on the market. Incorrect classification, incomplete documentation, or non-compliant labelling can result in product refusal, enforcement action, or forced reformulation.
gcrs group supports Japanese and international brands with structured, end-to-end compliance, ensuring obligations are met before launch and maintained throughout the product lifecycle. With regulatory teams across Japan, ASEAN, EU, UK, USA, India, and GCC, we align Japanese compliance seamlessly with your wider global strategy.
Japan Compliance Timeline
Japan Cosmetic Compliance Requirements
Cosmetics placed on the Japanese market must comply with the PMD Act and applicable Ministry of Health, Labour and Welfare (MHLW) standards.
Japan Compliance Checklist:
Before a cosmetic product can be sold in Japan, the following must be in place:
- Appointed Japanese MAH (local responsible entity)
- Correct cosmetic vs quasi-drug classification
- Ingredient compliance with Japanese standards
- Product safety substantiation available
- Japan-compliant labelling and warnings
- Claims reviewed for PMD Act compliance
- Import and distribution readiness
- Post-market surveillance procedures
Failure to comply may result in product rejection, recall, or regulatory enforcement.
How gcrs group Supports Global Compliance
Market Entry Support for Japan
Entering the Japanese market requires careful coordination of classification, documentation, local accountability, and compliance review.
gcrs group provides structured Japan market entry support, including:
- Regulatory pathway analysis
- MAH coordination support
- Ingredient and formulation review
- Safety documentation alignment
- Label and artwork compliance
- Import and distribution guidance
- Alignment with wider Asia-Pacific strategy
Our approach ensures products enter the Japanese market smoothly, legally, and without unnecessary delay. Explore Responsible Person & MAH alignment support:
PMD Act Cosmetic Compliance
(Legal Accountability & Compliance Control)
Compliance under Japan’s PMD Act is the core legal requirement for placing cosmetic products on the Japanese market. Products must comply with approved ingredient standards, safety requirements, and labelling rules, with additional obligations for quasi-drugs.
Under Japanese law, the local MAH is legally accountable for:
- Product classification accuracy
- Ingredient and formulation compliance
- Labelling and claims
- Safety substantiation
- Post-market surveillance and reporting
Misclassification between cosmetics and quasi-drugs is one of the most common causes of market delays and enforcement issues.
gcrs group manages Japanese cosmetic compliance on your behalf, providing structured, inspection-ready regulatory control.
Our Japan cosmetic compliance services include:
- PMD Act regulatory pathway assessment
- Cosmetic vs quasi-drug classification
- Ingredient and formulation compliance review
- Safety documentation support
- Label and artwork compliance review
- MAH support and coordination
By working with GCRS, your Japan compliance is defensible, accurate, and aligned with enforcement expectations.
Japan Cosmetic Labelling Requirements
Labelling is a high-risk area for cosmetic compliance in Japan and a frequent cause of regulatory challenge.
Cosmetic labels must include:
- Product name and function
- Ingredient listing (Japanese naming conventions)
- Net content
- MAH name and address
- Batch or lot number
- Usage instructions and warnings
- Japanese language compliance
- Claims aligned with cosmetic classification
gcrs group reviews labels to ensure PMD Act compliance, while maintaining consistency with EU, UK, and global artwork wherever possible.
Cosmetic vs Quasi-Drug Classification in Japan
Japan’s regulatory system distinguishes clearly between cosmetics and quasi-drugs, with quasi-drugs subject to stricter controls and pre-approval.
Classification depends on:
- Product function and intended use
- Active ingredients
- Claims and marketing language
- Concentration thresholds
Incorrect classification can significantly delay market entry or trigger enforcement action.
gcrs group supports brands with classification assessment, risk analysis, and regulatory positioning to ensure products follow the correct approval pathway.
Support for International Brands Entering Japan
Global documentation from the EU, UK, or USA does not automatically meet Japanese requirements. Differences in ingredient standards, labelling format, claims control, and classification often create compliance gaps.
gcrs group bridges these gaps by:
- Translating global documentation for PMD Act alignment
- Identifying ingredient or formulation risks
- Adapting labels and claims for Japan
- Supporting MAH appointment and obligations
- Aligning Japanese compliance with regional strategy
This ensures a controlled, compliant transition into the Japanese market.
Japan vs UK vs EU Cosmetic Regulation
Topic
Regulatory Authority
Primary Regulation
Responsible Entity
Market Entry Requirement
Safety & Technical Documentation
Language Requirements
Japan
Ministry of Health, Labour and Welfare (MHLW) & Pharmaceuticals and Medical Devices Agency (PMDA)
PMD Act
Marketing Authorisation Holder (MAH)
Product classification (Cosmetic/Quasi-drug); MAH required
Safety data required; documentation retained by MAH
Japanese language; PMD Act compliant
UK
Office for Product Safety & Standards (OPSS)
UK Cosmetics Regulation
UK Responsible Person (RP)
SCPN notification before sale
CPSR & PIF required
English with UK RP details
EU
European Commission (EC) & Member State Competent Authorities
EU Cosmetics Regulation (EC) No. 1223/2009
EU Responsible Person (RP)
CPNP notification before sale
CPSR & PIF required
Local EU language(s) with EU RP details
While the UK and EU rely on Responsible Person models and pre-market notification, Japan operates under the PMD Act, requiring products to be correctly classified as cosmetics or quasi-drugs and managed by a local Marketing Authorisation Holder (MAH). Japan also has its own safety documentation and Japanese-language labelling requirements. Understanding these regulatory differences is essential for successful market entry. gcrs group supports cosmetics, fragrance, personal care, food and dietary supplement brands with regulatory compliance and market access across more than 125 countries.
What gcrs group Does for You
As your Japan cosmetic compliance partner, gcrs group delivers end-to-end regulatory support:
- PMD Act compliance management
- Cosmetic and quasi-drug classification
- Ingredient and formulation review
- Label and artwork correction
- MAH support and coordination
- Market entry strategy
- Ongoing regulatory monitoring
- CRFT platform for document control and visibility
We ensure your products meet Japanese regulatory expectations and remain compliant throughout their lifecycle.
Frequently Asked Questions
Do cosmetics need approval before sale in Japan?
Cosmetics do not require pre-approval, but must meet PMD Act requirements and be correctly classified.
Who is legally responsible for cosmetic compliance in Japan?
The local Marketing Authorisation Holder (MAH).
What is a quasi-drug in Japan?
Products with active ingredients or specific functional claims that fall between cosmetics and pharmaceuticals.
Can EU-compliant cosmetics be sold directly in Japan?
No. Separate classification, labelling, and compliance alignment is required.
How long does Japan cosmetic compliance preparation take?
Timelines depend on classification, formulation complexity, and documentation readiness.